Oxolamine

DB13216ApprovedSmall molecule

Oxolamine is a medication indicated in the treatment of a cough or upper respiratory tract inflammation. Oxolamine is not approved in the USA, it may be marketed elsewhere internationally as a cough suppressant.

Formula / weight: C₁₄H₁₉N₃O · 245.326 g/mol (avg)
Code names: 683 M · AF 438

Resolves to

Compound

UNII90BEA145GYCAS959-14-8ChEMBLCHEMBL1620875ChEBI94607

Clinical / RWD

RxNorm32658ATCR05DB07

Structure

InChIKeyIDCHQQSVJAAUQQ-UHFFFAOYSA-NSMILESCCN(CC)CCC1=NC(=NO1)C1=CC=CC=C1

What you can answer from here — as of August 30, 2026

7Structured indicationsCondition, population, route and combination as fields, not prose

6ContraindicationsEach with its own population and attribute set

35Marketed productsAcross 2 countries and 17 labellers

1ATC codeIncluding every combination product, plus 5 drug categories

5+ReferencesStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Oxolamine, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account